Vitamin D levels and early mortality among incident hemodialysis patients.

[1]  Z. Massy,et al.  Vitamin D levels and early mortality among incident hemodialysis patients. , 2008, Kidney international.

[2]  N. Futrakul,et al.  Altered vascular homeostasis in chronic kidney disease. , 2008, Clinical hemorheology and microcirculation.

[3]  M. Rastaldi,et al.  Apoptosis in the kidneys of patients with type II diabetic nephropathy. , 2007, Kidney international.

[4]  R. Recker,et al.  Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. , 2007, The American journal of clinical nutrition.

[5]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.

[6]  V. Sitprija,et al.  Improvement of Renal Function in Type 2 Diabetic Nephropathy , 2007, Renal failure.

[7]  E. Bedrick,et al.  Mortality risk among hemodialysis patients receiving different vitamin D analogs. , 2006, Kidney international.

[8]  J. O'riordan.  Rickets in the 17th Century , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  M. Budoff,et al.  Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. , 2006, Kidney international.

[10]  P. Lips,et al.  High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands , 2006 .

[11]  N. Powe,et al.  Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. , 2006, Kidney international.

[12]  M. Drezner,et al.  HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. , 2006, Clinical chemistry.

[13]  Yan Liu,et al.  Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. , 2006, Journal of the National Cancer Institute.

[14]  M. Holick.  High prevalence of vitamin D inadequacy and implications for health. , 2006, Mayo Clinic proceedings.

[15]  J. Manson,et al.  Vitamin D and calcium intake in relation to type 2 diabetes in women. , 2006, Diabetes care.

[16]  P. Glendenning,et al.  Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays , 2006, Annals of clinical biochemistry.

[17]  E. Bonucci,et al.  25-hydroxyvitamin D levels and bone histomorphometry in hemodialysis renal osteodystrophy. , 2005, Kidney international.

[18]  K. Berta,et al.  Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis. , 2005, Clinical nephrology.

[19]  R. Koerfer,et al.  Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.

[20]  S. Rainbow,et al.  Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3. , 2005, Clinical chemistry.

[21]  A. Meikle,et al.  Measurement of 25-hydroxyvitamin D by the Nichols ADVANTAGE, DiaSorin LIAISON, DiaSorin RIA, and liquid chromatography-tandem mass spectrometry. , 2005, Clinical chemistry.

[22]  W. März,et al.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. , 2005, The New England journal of medicine.

[23]  C. Cowell,et al.  The re-emerging burden of rickets: a decade of experience from Sydney , 2005, Archives of Disease in Childhood.

[24]  M. Holick,et al.  Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  S. Moe,et al.  Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  V. Das,et al.  High prevalence of vitamin D deficiency among pregnant women and their newborns in northern India. , 2005, The American journal of clinical nutrition.

[27]  N. Stern,et al.  25-Hydroxyvitamin D3-1α-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is Upregulated by Parathyroid Hormone and Estrogenic Compounds , 2005, Circulation.

[28]  M. Hernán,et al.  Activated injectable vitamin D and hemodialysis survival: a historical cohort study. , 2005, Journal of the American Society of Nephrology : JASN.

[29]  N. Futrakul,et al.  Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. , 2005, Clinical hemorheology and microcirculation.

[30]  Guilin Qiao,et al.  Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. , 2005, American journal of physiology. Endocrinology and metabolism.

[31]  W. Willett,et al.  Vitamin D intake and incidence of multiple sclerosis , 2004, Neurology.

[32]  D. Oliver,et al.  Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. , 2004, American journal of nephrology.

[33]  R. Thadhani,et al.  Vitamin D receptor and analogs. , 2004, Seminars in nephrology.

[34]  S. Fukumoto,et al.  Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  G. Eknoyan,et al.  Bone metabolism and disease in chronic kidney disease , 2003 .

[36]  Keith C. Norris,et al.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  M. Wolf,et al.  Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. , 2003, The New England journal of medicine.

[38]  A. Fournier,et al.  Sevelamer hydrochloride with or without alphacalcidol or higher dialysate calcium vs calcium carbonate in dialysis patients: an open-label, randomized study. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  G. Tenderich,et al.  Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? , 2003, Journal of the American College of Cardiology.

[40]  Johanna T Dwyer,et al.  Effect of dialysis dose and membrane flux in maintenance hemodialysis. , 2002, The New England journal of medicine.

[41]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[42]  M. Cogswell,et al.  Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. , 2002, The American journal of clinical nutrition.

[43]  D. Wheeler,et al.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.

[44]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[45]  Elina Hyppönen,et al.  Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study , 2001, The Lancet.

[46]  K. Ge,et al.  Vitamin D deficiency and associated factors in adolescent girls in Beijing. , 2001, The American journal of clinical nutrition.

[47]  R. Wood,et al.  1,25-Dihydroxyvitamin D3 increases the expression of the CaT1 epithelial calcium channel in the Caco-2 human intestinal cell line , 2001, BMC Physiology.

[48]  A. Howie,et al.  Extrarenal Expression of 25-Hydroxyvitamin D3-1α-Hydroxylase1 , 2001 .

[49]  W. Owen,et al.  Limitations of the facility-specific standardized mortality ratio for profiling health care quality in dialysis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[50]  P M Stewart,et al.  Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. , 2001, The Journal of clinical endocrinology and metabolism.

[51]  E. Ritz,et al.  Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[52]  Per Kragh Andersen,et al.  Modern Epidemiology. 2nd edn. Kenneth J. Rothman and Sander Greenland, Lippincott‐Raven, U.S.A., 1998. No. of pages: 737. Price: $74.50. ISBN 0‐316‐75780‐2 , 2000 .

[53]  J. Achard,et al.  Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol? , 1999, Kidney international.

[54]  M. Emoto,et al.  Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. , 1999, Kidney international.

[55]  R. Foley,et al.  Clinical epidemiology of cardiovascular disease in chronic renal disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[56]  A R Nissenson,et al.  The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. , 1998, The New England journal of medicine.

[57]  Barrett T. Kitch,et al.  Hypovitaminosis D in medical inpatients. , 1998, The New England journal of medicine.

[58]  H. van den Berg,et al.  Serum vitamin D concentrations among elderly people in Europe , 1995, The Lancet.

[59]  J. Wu,et al.  1,25(OH)2D3 suppresses expression and secretion of atrial natriuretic peptide from cardiac myocytes. , 1995, The American journal of physiology.

[60]  R. Bouillon,et al.  Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.

[61]  I. Khan,et al.  Death during the first 90 days of dialysis: a case control study. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[62]  B. Hollis,et al.  Defective photoproduction of cholecalciferol in normal and uremic humans. , 1984, The Journal of nutrition.

[63]  W. Loomis.  Skin-Pigment Regulation of Vitamin-D Biosynthesis in Man , 1967, Science.